Trump's nomination went sour, Acreage shareholders are worried, plus a Canadian cannabis tech analysis.
Discover hemp fiber’s rise in US manufacturing and Canada’s cannabis budget challenges.
Trump appointees to lead the war on drugs, earnings keep rolling in, and news from cannabis around the globe.
RIV’s booming Q3, global cannabis setbacks, & Big Pharma’s plans—Black Friday Frenzy
Plus Musk’s potential $40B DEA cutback and Mexico’s President's strong position on fentanyl.
Thanksgiving buzz: Canopy’s shareholder challenges, and a December hearing that could reshape cannabis policy.
Biden’s unkept cannabis pardon promises, DEA faces bias claims, industry updates, and Elon Musk’s controversial Pablo Escobar meme.
DEA corruption claims and shifting cannabis regulations collide ahead of a crucial Dec. 2 hearing.
Innocan & Vext report strong growth, Agrify secures $25.9M, & Germany’s medical cannabis market heats up.
Transparency Battles, Tax Talks, & Cannabis Automation Reviving the American Dream
From digital dollars to hemp amendments and pre-roll power, here’s how Trump’s win is rewriting the cannabis playbook.
Dive into cannabis's crossroads—balancing distress and opportunity, women cultivating change at home, and new horizons in research and global policy shifts.
